King & Spalding LLP focuses on regulatory advice in the life sciences sector at the interfaces with food, pharmaceutical and medical device law, which leads to frequent instructions pertaining to product launches, market entry and recalls as well as compliance. The team also represents clients in competition law proceedings, such as parallel import proceedings. This expertise is evident in a recently obtained groundbreaking judgment for the pharmaceutical market, where practice head Ulf Grundmann took the lead. Counsel Elisabeth Kohoutek complements this with experience in M&A transactions, here, the practice regularly cooperate with the international network.
Testimonials
Collated independently by Legal 500 research team.
- 'King & Spalding is one of the leading law firms for parallel trade cases and trademarks in the pharmaceutical industry. They have represented various pharmaceutical companies at all judicial levels, including before the Court of Justice of the European Union.'
- 'King & Spalding has deep expertise in trademark law for the pharmaceutical industry.'
- 'Ulf Grundmann is very experienced. What sets him apart is his ability to think outside the box - his legal strategies are very creative yet highly effective.'
Key clients
- Novartis Pharma AG
- ratiopharm GmbH
- GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare
- biomo Group
- Angelini Pharma Deutschland GmbH
- Teva Pharmaceuticals Europe B.V. und Teva GmbH
- Dr. Willmar Schwabe GmbH & Co. KG
- Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)
- Roche Diagnostics
- Chemische Fabrik Kreussler Co. GmbH
- DR. KADE Pharmazeutische Fabrik GmbH
- Diagnostic Green
- SGF International e.V.
- Eckes-Granini Group
- Heilerde-Gesellschaft Luvos Just GmbH & Co. KG
- MODJAW SAS
- AgNovos Healthcare
Work highlights
- Representation of Novartis Pharma AG as the original manufacturer in the submission procedure before the ECJ regarding the parallel import of pharmaceuticals.
- Advising GSK Consumer Healthcare in a competition dispute regarding advertising claims for the Vitasprint Pro Immun product.
- Advising the French medical technology company MODJAW SAS in a competition dispute against zebris GmbH in connection with a medical device and its classification as a medical device.
Practice head
The lawyer(s) leading their teams.
Ulf Grundmann